Skip to content
OpenCapital
Get started

Cencora COR Other non-strategic businesses — Revenue

Other product segments

Alliance Healthcare
$6.52B+12.9%
Animal Health
$1.44B+5.3%
Other Healthcare Solutions
$1.05B+13.5%

Similar metrics at other companies

Organon logo
OGNOther — Revenue
$87M+11.5%
Constellium logo
CSTMAll other — Revenue
$404.25M+8.6%
Concentrix Corporation logo
CNXCOthers — Revenue
$1.27B+6.2%
Mistras Group logo
MGOther — Revenue
-$5.23M-45.6%
Getty Images logo
GETYOther — Revenue
$8.64M-7.0%
Imax logo
IMAXAll Other — Revenue
$1.67M-8.4%

Other financials

Income statement

See full
Revenue$78.4B+3.8%
Gross profit$3.6B+17.3%
Operating income$1.1B+10.3%
Net income$1.6B+129%
EPS (diluted)$8.40+128%

Balance sheet

See full
Cash & equivalents$2.2B+10.0%
Total debt$12.2B+71.9%
Total equity$3.4B+235%
Total assets$81.7B+14.7%

Cash flow

See full
Operating cash flow-$2.3B+15.2%
CapEx$165.6M+28.3%
Free cash flow-$2.4B+14.2%

Valuation

See full
Market cap$55.83B-1.9%
Enterprise value$65.84B+6.1%
P/E15.5×+3.1×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.4pp
Operating margin0.8%0.0pp
Net margin0.6%-0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Return on equity130.6%-99.8pp
Debt / equity3.6×-3.4×
Current ratio0.9×+0.1×

Where this comes from

Reported directly by Cencora in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Cencora’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cencora's other non-strategic businesses — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cencora's other non-strategic businesses — revenue?
Cencora (COR) reported other non-strategic businesses — revenue of $619.78M in Q1 2026.
What does other non-strategic businesses — revenue mean?
This metric represents the total revenue generated from business units or service lines that are considered non-core to the company's primary pharmaceutical distribution and commercialization operations. These activities typically include legacy services, ancillary business ventures, or discontinued operations that do not align with the long-term strategic focus of the organization. Tracking this revenue helps investors isolate the performance of the core business from peripheral or winding-down segments.